Invitae to Present at the TD Cowen 43rd Annual Health Care Conference Mar 1, 2023 04:05PM
UPDATE: Cowen Downgrades Invitae Corporation (NVTA) to Market Perform Jul 26, 2022 05:46AM
Invitae Corporation (NVTA) PT Lowered to $8 at Cowen Jul 19, 2022 09:14AM
Invitae to Present at Upcoming Investor Conferences Feb 3, 2022 04:01PM
InVitae (NVTA) to acquire Genosity Apr 5, 2021 07:30AM


Apr 5, 2021 07:30AM Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide
Feb 22, 2021 04:05PM Invitae to Present at The Cowen 41st Annual Healthcare Conference
Jan 26, 2021 04:05PM Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Underwritten Public Offering
Jan 22, 2021 05:57AM InVitae (NVTA) Prices 7.77M Share Common Offering at $51.50/Sh
Jan 21, 2021 08:37PM Invitae Announces Pricing of Public Offering of Common Stock
Jan 20, 2021 04:06PM InVitae (NVTA) Announces Proposed $400M Share Common Offering
Jan 20, 2021 04:05PM Invitae Announces Proposed Public Offering of Common Stock
Nov 6, 2020 07:06AM Invitae Corporation (NVTA) PT Raised to $50 at Cowen
Jun 26, 2020 06:18AM Invitae Corporation (NVTA) PT Raised to $35 at Cowen
Jun 22, 2020 07:11AM InVitae (NVTA) to Combine with ArcherDX
Jun 22, 2020 07:00AM Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Apr 6, 2020 04:05PM Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Underwritten Public Offering
Apr 2, 2020 05:54AM InVitae (NVTA) Prices 17.78M Share Common Offering at $9/Sh
Apr 1, 2020 10:48PM Invitae Announces Pricing of Public Offering of Common Stock
Apr 1, 2020 04:19PM InVitae (NVTA) to Offer $125M in Common Stock
Apr 1, 2020 04:17PM Invitae Announces Proposed Public Offering of Common Stock
Feb 25, 2020 07:27AM Invitae to Present at the Cowen and Company's 40th Annual Health Care Conference
Feb 20, 2020 08:44AM Invitae Corporation (NVTA) PT Raised to $30 at Cowen
Jun 28, 2019 07:41AM Cowen Reiterates Outperform Rating on Invitae Corporation (NVTA)
Mar 6, 2019 09:31PM Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock
Mar 6, 2019 05:58AM InVitae (NVTA) Prices 9M Share Common Offering at $19/Sh
Mar 5, 2019 08:19PM Invitae Announces Pricing of Public Offering of Common Stock
Mar 4, 2019 04:08PM InVitae (NVTA) Commences $125M Public Offering of Common Stock
Mar 4, 2019 04:07PM Invitae Announces Proposed Public Offering of Common Stock
Mar 28, 2018 08:54AM Pre-Open Movers 03/28: (AQMS) (RSPP) (SHPG) Higher; (EDGE) (APRI) (NVTA) Lower (more...)
Mar 28, 2018 06:03AM InVitae (NVTA) Prices 11.1M Shares at $4.50
Mar 28, 2018 06:00AM Invitae Announces Pricing of Public Offering of Common Stock
Mar 26, 2018 04:05PM InVitae (NVTA) Announces $50M Share Common Offering
Mar 26, 2018 04:05PM Invitae Announces Proposed Public Offering of Common Stock
Feb 26, 2018 07:30AM Invitae to present at the Cowen and Company 38th Annual Health Care Conference
Jul 31, 2017 04:54PM Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth Opportunities and Reports Preliminary Second Quarter Financial Results
Feb 21, 2017 11:07AM Invitae to present at the Cowen and Company 37th Annual Health Care Conference
Nov 17, 2016 07:31AM InVitae (NVTA) Prices 7.33M Shares at $6/Sh
Nov 17, 2016 07:30AM Invitae Announces Pricing of Public Offering of Common Stock
Feb 23, 2016 09:00AM Invitae to Present at the Cowen and Company 36th Annual Health Care Conference
Mar 9, 2015 07:01AM Cowen Starts Invitae Corporation (NVTA) at Outperform
Feb 12, 2015 09:56AM Invitae (NVTA) IPO Opens Up 9%